Objective Evaluation of the Therapeutic Effects of Oral Steroids in the Management of Biliary Atresia Therapeutic Effects of Oral Steroids in Biliary Atresia
Iranian Journal of Pediatric Surgery,
Vol. 8 No. 1 (2022),
Introduction: Biliary atresia is a progressive fibro-obliterativecholangiopathy that affects both intrahepatic and extrahepatic biliary ducts causing cholestasis and neonatal jaundice. The use of anti-inflammatory agents such as corticosteroids may decrease inflammation and recurrent stricture.
Materials and Methods: This clinical trial had been performed on 24 patients admitted to Children’s Hospital with biliary atresia. Prednisolone was not administered in the control group after the operation, but in the intervention group, 2 mg/kg/day of prednisolone was given for 6 weeks and then tapered. Then, its therapeutic effect in the management of biliary atresia was compared.
Results: The mean age of the patients in the case and control groups was 2.19 and 2 months, respectively. Cholangitis (P= 0.3), direct hyperbilirubinemia (P= 0.6), ascites (P= 0.5), pigmented stools (P= 0.7), and esophageal varices (P= 0.1) between the two groups was not significant. But the age of the patients, outcome of treatment (P= 0.05), total hyperbilirubinemia (P= 0.05), growth failure (P=0.03), worsening grade of splenomegaly (P= 0.04), hepatomegaly (P= 0.03), fecal pigmentation (P= 0.003), death (P= 0.01), and portal hypertension (P= 0.02) in two groups were significant.
Conclusion: Regarding the results, corticosteroids have a significant effect on reducing the bilirubin levels, improving the survival rate, and decreasing the mortality rate, although these results are closely related to the patient’s age at the time of surgery.
- Biliary atresia
- Kasai procedure
How to Cite
Hartley JL, Davenport M, Kelly DA: Biliary atresia. Lancet 2009; 374:1704–1713.
Bassett MD, Murray KF: Biliary atresia: recent progress. J Clin Gastroenterol 2008; 42:720–729.
Ullah S, Rahman K, Hedayati M: Hyperbilirubinemia in neonates: types, causes, clinical examinations, preventive measures, and treatments: a narrative review article. Iran J Public Health 2016; 45:558–568.
Davenport M, Stringer MD, Tizzard SA, et al: Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia. Hepatology 2007; 46:1821–1827.
Patel KR, Harpavat S, Khan Z, et al: Biliary atresia patients with successful Kasai portoenterostomy can present with features of obliterative portal venopathy. Journal of pediatric gastroenterology and nutrition 2020;71(1):91-8.
Coran AG, Caldamone A, Adzick NS, et al: Pediatric surgery e-book. Elsevier Health Sci 2012; 2:1327.
Hidangmayum A, Bhat SP, Teerthanath S, et al: Neonatal giant cell hepatitis secondary to extrahepatic biliary atresia associated with choledochal cyst 2021.
Feldman AG, Sokol RJ: Recent developments in diagnostics and treatment of neonatal cholestasis. Seminars in Pediatric Surgery 2020: Elsevier.
Hsiao CH, Chang MH, Chen HL, et al: Universal screening for biliary atresia using an infant stool color card in Taiwan. Hepatology 2008; 47:1233–1240.
Sun LS, Saraiya NR, Houck PJ: Anesthesia for Abdominal Surgery. Gregory's Pediatric Anesthesia 2020:793-812.
Wang P, Li D, Jiao C, et al: Intravenous antibiotics for the treatments of cholangitis after Kasai operation in biliary atresia patients. 2020.
Baek SH, Kang J-M, Ihn K, et al: The Epidemiology and etiology of cholangitis after kasaiportoenterostomy in patients with biliary atresia. Journal of pediatric gastroenterology and nutrition 2020; 70(2):171-7.
Zhang D, Yang HY, Jia J, et al: Postoperative steroids after Kasai portoenterostomy for biliary atresia: a meta-analysis. Int J Surg 2014; 12:1203–1209.
Dong R, Song Z, Chen G, et al: Improved outcome of biliary atresia with postoperative high-dose steroid. Gastroenterol Res Pract 2013; 2013:902431.
- Abstract Viewed: 32 times
- PDF Downloaded: 62 times